Upstream Bio, Inc.
Company Stats
- Market Cap
- $288.6M
- as of Sep 30, 2026
- Shares Outstanding
- 54.8M
- Free Float
- 63.6%
Income Statement
- Revenue
- $2.9M
- Operating Income
- -$160.4M
- Net Income
- -$143.4M
- EBITDA
- -$160.2M
- FCF Margin, 3Y Avg
- -2931.1%
- FCF Margin, Worst Year
- -4675.5%
Cash Flow
- Free Cash Flow
- -$133.4M
- FCF Yield
- -46.2%
- Owner FCF Yield
- -49.8%
Balance Sheet
- Cash & Equivalents
- $101.6M
Returns & Capital
- SBC, 3Y Avg
- $6.6M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $2.9M | -$133.4M | -4675.5% |
| FY2024 | $2.4M | -$59.7M | -2518.3% |
| FY2023 | $2.4M | -$38.1M | -1599.6% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 6, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges